Ausgabe 2/2016
Inhalt (14 Artikel)
Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations
Javier Puente, Xavier García del Muro, Álvaro Pinto, Nuria Láinez, Emilio Esteban, José Ángel Arranz, Enrique Gallardo, María José Méndez, Pablo Maroto, Enrique Grande, Cristina Suárez
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
Roberto Iacovelli, Franco Nolè, Elena Verri, Giuseppe Renne, Chiara Paglino, Matteo Santoni, Maria Cossu Rocca, Palma Giglione, Gaetano Aurilio, Daniela Cullurà, Stefano Cascinu, Camillo Porta
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors
Rodrigo Dienstmann, Ulrik Lassen, Jonathan Cebon, Jayesh Desai, Michael P. Brown, Stefan Evers, Fei Su, Weijiang Zhang, Frederic Boisserie, Brian Lestini, Kathleen Schostack, Valerie Meresse, Josep Tabernero
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study
S. Vatrano, L. Righi, T. Vavalá, I. Rapa, M. Busso, S. Izzo, S. Cappia, A. Veltri, M. Papotti, G. V. Scagliotti, S. Novello
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study
J. B. Auliac, C. Fournier, C. Audigier Valette, M. Perol, A. Bizieux, F. Vinas, C. Decroisette Phan van Ho, S. Bota Ouchlif, R. Corre, G. Le Garff, P. Fournel, N. Baize, R. Lamy, A. Vergnenegre, D. Arpin, B. Marin, C. Chouaid, R. Gervais
Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan
Hideaki Miyake, Akira Miyazaki, Satoshi Imai, Ken-ichi Harada, Masato Fujisawa
Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy
Daniela Laura Papademetrio, Silvina Laura Lompardía, Tania Simunovich, Susana Costantino, Cintia Yamila Mihalez, Victoria Cavaliere, Élida Álvarez
RETRACTED ARTICLE: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8
Ying Wang, Po Xu, Jun Yao, Ruina Yang, Zhenguo Shi, Xiaojuan Zhu, Xiaoshan Feng, Shegan Gao
Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)
S S Islam, R B Mokhtari, P Akbari, J Hatina, H Yeger, W A Farhat
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib
Ying Chen, Brian I. Rini, Robert J. Motzer, Janice P. Dutcher, Olivier Rixe, George Wilding, Walter M. Stadler, Jamal Tarazi, May Garrett, Yazdi K. Pithavala
Vemurafenib-induced progression of breast cancer: a case report and review of the literature
Aleksei V. Novik, Svetlana A. Protsenko, Irina A. Baldueva, Aleksander O. Ivantsov, Tatyana L. Nekhaeva, Zinaida Y. Akhaeva, Grigoriy A. Yanus, Aglaya G. Iyevleva, Evgeny N. Imyanitov
Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma
Celeste B. Burness, Lesley J. Scott
Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma
Sheridan M. Hoy